TGA Approval

SITAGLIPTIN/METFORMIN XR MK 50/1000 sitagliptin (as phosphate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle (443393)

ARTG ID

443393

ARTG Name

SITAGLIPTIN/METFORMIN XR MK 50/1000 sitagliptin (as phosphate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle

Sponsor

Maple Healthcare Pty Ltd

ARTG Date

March 20, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Maple Healthcare Pty Ltd

Sponsor Item Name

MAPLE HEALTHCARE PTY LTD

Active Ingredients

Ingredient Name

metformin hydrochloride

Ingredient Name

sitagliptin phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

SITAGLIPTIN/METFORMIN XR MK 50/1000 sitagliptin (as phosphate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle (443393) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

SITAGLIPTIN/METFORMIN XR MK 50/1000 sitagliptin (as phosphate)/metformin hydrochloride 50 mg/1000 mg extended release tablet bottle (443393)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal